Unveiling a Rare Case: Madras Motor Neuron Disease in an 18-Year-Old Patient

Keyur Saboo1, Sourya Acharya1, Sunil Kumar1

  • 1Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

Cureus
|June 10, 2024
PubMed

Insights

This study details a unique case of Madras motor neuron disease (MMND) in an 18-year-old, challenging typical disease onset. The rare condition presented with rapid progression and severe motor neuron symptoms in a young adult.

Area of Science:

  • Neurology
  • Rare Diseases
  • Neurodegenerative Disorders

Background:

  • Madras motor neuron disease (MMND) is typically a childhood or juvenile-onset motor neuron disease.
  • Understanding of MMND's typical presentation and progression is limited due to its rarity.

Observation:

  • A unique case of MMND is presented in an 18-year-old patient, deviating from the usual age of onset.
  • The patient exhibited insidious onset of progressive quadriparesis, muscle wasting, tongue fasciculation, and sensorineural hearing loss.
  • Clinical course showed rapid deterioration and significant functional impairment despite supportive and symptomatic management.

Findings:

  • Neurological examination confirmed lower motor neuron involvement.
  • Electromyography (EMG) and nerve conduction studies (NCS) supported the diagnosis of MMND.
  • The disease progression was relentless, underscoring the aggressive nature of this atypical presentation.

Implications:

  • This case broadens the differential diagnosis for motor neuron diseases in adolescents and young adults.
  • Highlights the need for further research into MMND's underlying mechanisms.
  • Emphasizes the importance of exploring potential therapeutic strategies for this uncommon ailment.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
767